Baillie Gifford
Amyris, Inc.
Zymergen
Precigen
Roche
Y Combinator
Viking Global Investors
10x Genomics
Qiagen
Sequoia Capital
Jane Street Capital
Moderna
Novartis
Amgen
Motley Fool via Yahoo
Why Ginkgo Bioworks Stock Is Sinking Today
2 days ago
FierceBiotech
Ginkgo Bioworks to lay off as many as 400 employees
10 hours ago
ETF DAILY NEWS
Traders Purchase Large Volume of Ginkgo Bioworks Call Options (NYSE:DNA)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Get Free Report) was the target of unusually large options trading on Thursday. Stock traders purchased 8,763 call options on the company. This is ...
21 hours ago
InvestorPlace
Ginkgo Bioworks Layoffs Expand to 400 Job Cuts
The Boston Globe
Ginkgo Bioworks plans to lay off more than a third of its workers - The Boston Globe
3 days ago
The Business Journals
Ginkgo job cuts to hit at least 35% of workforce; as many as 400 jobs to be cut - San Francisco Business Times
GenomeWeb News
Ginkgo Bioworks to Lay Off 35 Percent of Workforce
Ginkgo Bioworks plans to lay off more than a third of its workforce by sometime in 2025, according to a Monday filing with the US Securities and Exchange Commission. According to the filing, ...
The Republican
Boston-based bio company to lay off more than 150 employees in Mass. with more to come
View all
American biotechnology company
ginkgobioworks.com
Ginkgo Bioworks is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. Wikipedia
More on Yahoo Finance